Merck ZooMAb recombinant antibodies

Merck’s ZooMAb recombinant antibodies have received an Accountability, Consistency and Transparency (ACT) label from My Green Lab, a non-profit organisation dedicated to creating a culture of sustainability in science. The antibodies received the lowest environmental impact factor (EIF) scores in the chemicals and reagents category.

Unlike traditional monoclonal antibodies, or mAbs, made from identical immune cells from an animal-sourced parent cell, ZooMAb antibodies use recombinant technology. This offers an endless and consistent supply while reducing the use of animals in research.

The antibodies can be shipped at room temperature and then stored between 2 and 8°C, unlike traditional mAbs that must be shipped and stored between 2 and 8°C, eliminating the need for specially insulated, ice-cooled containers that contribute to high packaging material consumption and transport emissions. The antibodies do not contain any Red List chemicals, CMRs, PBTs or GreenScreen Benchmark-1 chemicals.